Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Direct Oral Anticoagulants (DOACs) Once Daily (OD) Versus Direct Oral Anticoagulants (DOACs) Twice Daily (TD) Versus Low-Molecular-Weight Heparin (LMWH) for Thromboprophylaxis After Primary Total Knee Arthroplasty: A Duplex Ultrasound Assessment

NCT07869615 is registered in ClinicalTrials.gov with Military Hospital of Tunis as lead sponsor.

NCT NCT07869615
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07869615 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Direct Oral Anticoagulants (DOACs) Once Daily (OD) Versus Direct Oral Anticoagulants (DOACs) Twice Daily (TD) Versus Low-Molecular-Weight Heparin (LMWH) for Thromboprophylaxis After Primary Total Knee Arthroplasty: A Duplex Ultrasound Assessment
Lead sponsor
Military Hospital of Tunis
Phase
Not applicable
Overall status
Recruiting
Start date
September 15, 2026
Completion date
April 15, 2027
Enrollment
138 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

venous thromboembolism prevention after total knee arthroplasty